Details of the Drug Reposition

General Information of This Drug (ID: DMZX0VF)

Drug Name
Tavokinogene telseplasmid   DMZX0VF
Synonyms TAVO
Drug Type
Gene therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Melanoma DIS1RRCY 2C30 Phase 2 [1]
Triple negative breast cancer DISAMG6N 2C60-2C65 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)